Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.52 | 4.81 |
| PEG Ratio (TTM) | -0.26 | -1.08 |
| P/S Ratio (TTM) | 5.82 | 51.93 |
| P/B Ratio (TTM) | 0.96 | 0.94 |
| P/FCF Ratio (TTM) | 5.17 | 18.49 |
| Price to 5YR AVG Earnings Ratio | 19.80 | 26.70 |
| Price to 5YR AVG FCF Ratio | 1.86 | 29.10 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.85% | 1.17% |
| ROE (TTM) | 13.18% | 5.34% |
| Net Profit Margin (TTM) | 97.95% | 28.56% |
| ROIC 5YR AVG | 3.67% | 7.78% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -12.10% | -25.82% | 25.79% |
| Revenue | 6.31% | 13.53% | 64.34% |
| Net Income | 1.05% | -14.06% | 41.10% |
| Cash Flow | -7.11% | 1,998.46% | 1,185.57% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.27 | 1.63 |
| Quick Ratio (TTM) | 0.27 | 1.59 |
| D/E Ratio (TTM) | 0.08 | 0.72 |
| Interest Coverage (TTM) | 30.15 | 19.98 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 2.70 | 7.47 |
| LTL to 5YR AVG FCF | N/A | 9.40 |
| Shares Outstanding Growth 5YR AVG | -6.72% | -0.98% |